Product
MK-2214
1 clinical trial
1 indication
Indication
Alzheimer's diseaseClinical trial
A Multiple Ascending Dose Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-2214 in Adults With Mild Cognitive Impairment or Mild-to-Moderate Alzheimer's DiseaseStatus: Recruiting, Estimated PCD: 2025-05-16